Jianming Lu

16PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsMedical devicesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 18, 2026
Chemo-photothermal synergy ignites antitumor immunity via ferroptosis.

Jundong Lin, Huikang Yang, Zhihao Zou

|Jan 08, 2026
Exosome-transmitted long noncoding RNA SNHG1 promotes prostate cancer bone metastasis via YBX1/MMP16 axis.

Taowei Yang, Junqi Luo, Zining Long

|Nov 03, 2025
Unveiling HJURP as a Biomarker of Poor Prognosis and Immunotherapy Resistance in Lung Adenocarcinoma: A Multicenter Study.

Qinglin Tan, Peiliang Kong, Guobiao Chen

|Sep 24, 2025
Rare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers.

Yihao Chen, Le Zhang, Chuanfan Zhong

|Aug 13, 2025
Purine Nucleoside Phosphorylase (PNP) as a Biomarker and Therapeutic Target in Muscle-Invasive Bladder Cancer.

Yanfei Chen, Peiyi Xian, Jianming Lu

|Feb 25, 2025
Unveiling SMAD family member 6 as a novel biomarker for prognosis and immunotherapy response in testicular germ cell tumors.

Huawei Lin, Xiaowen Lin, Peisheng Huang

Pageof 3

Frequent Collaborators

3 joint publications

Weide Zhong

2 joint publications

Zhenyu Jia

1 joint publications

Yanqiong Zhang

1 joint publications

Chao Cai